Global and North America Limulus Amebocyte Lysate Market

Limulus Amebocyte Lysate Comprehensive Study by Type (Bacterial Endotoxins, Pyrogens - Biological Test), Application (Drug Testing, Clinical Diagnosis, Others), End User (Hospitals, Clinics, Healthcare Organizations, Healthcare Research Centers, Others) Players and Region - Global Market Outlook to 2030

Limulus Amebocyte Lysate Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Limulus Amebocyte Lysate
The Limulus amebocyte lysate test is a substitute method for the rabbit pyrogen test focussed on the detection of pyrogenic substances in germ-free parenteral medicines. The aim of Limulus amebocyte lysate is the evaluation and introduction to common day use of the LAL test gel-clot method for assay of bacterial endotoxins in the examined products. One of the most important aspects of the Limulus amebocyte lysate test is that it is in accordance with the latest demand of the European Pharmacopoeia Commission for the replacement of the animal-based tests in favor of alternative methods where possible.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR9.0%


Players in this market are small to medium companies. The market is fairly segmented and does not have any leaders. Local companies dominate in this market. As the largest chunk of this market is the B2B segment; signing long-term supply contracts with customers could be a good strategy to get a reliable source of revenue. Cost-effectiveness is key in this market.The Players having a strong hold in the market are Lonza Group AG, Charles River Laboratories, Inc., and ASSOCIATES OF CAPE COD, INC.. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Limulus Amebocyte Lysate market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Lonza Group AG (Switzerland), Charles River Laboratories, Inc. (United States), ASSOCIATES OF CAPE COD, INC. (United States), Accumedi Solutions Co., Ltd. (China), Xiamen Bioendo Technology (China), Zhanjiang A&C Biological (China), Zhanjiang Bokang (china) and Fuzhou Xinbei (China) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Limulus Amebocyte Lysate market by Type (Bacterial Endotoxins and Pyrogens - Biological Test), Application (Drug Testing, Clinical Diagnosis and Others) and Region.



On the basis of geography, the market of Limulus Amebocyte Lysate has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals will boost the Limulus Amebocyte Lysate market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
New Laboratory Method like Limulus Amebocyte Lysate (LAL) Test, Used for the Detection of Pyrogenic Endotoxins

Market Growth Drivers:
The Demand for the Quality of Drugs in Ever-Increasing is Surging and Advance in the Tests for the Purity of Human and Veterinary Drugs is Driving the Market

Challenges:
High Competetion

Restraints:
Strict Government Norms and Regulations

Opportunities:
Technological Advancement and Development of the Limulus Amebocyte Lysate Test is Creates the opportunities for Market

Market Leaders and their expansionary development strategies
In July 2020, Lonza Sales AG and Sanquin Reagents BV announced a strategic partnership to commercialize a collection of specialized reagents for the monocyte activation test-based pyrogen testing of parenteral pharmaceuticals and medical devices (MAT)
In August 2023, Lonza has launched the Nebula® Absorbance Reader, a new absorbance microplate reader which joins the company’s portfolio of optimized instruments for streamlined endotoxin and pyrogen testing.


Key Target Audience
Limulus Amebocyte Lysate Providers, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors and Other

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Bacterial Endotoxins
  • Pyrogens - Biological Test
By Application
  • Drug Testing
  • Clinical Diagnosis
  • Others
By End User
  • Hospitals
  • Clinics
  • Healthcare Organizations
  • Healthcare Research Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Demand for the Quality of Drugs in Ever-Increasing is Surging
      • 3.2.2. Advance in the Tests for the Purity of Human and Veterinary Drugs is Driving the Market
    • 3.3. Market Challenges
      • 3.3.1. High Competetion
    • 3.4. Market Trends
      • 3.4.1. New Laboratory Method like Limulus Amebocyte Lysate (LAL) Test, Used for the Detection of Pyrogenic Endotoxins
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Limulus Amebocyte Lysate, by Type, Application, End User and Region (value) (2018-2023)
    • 5.1. Introduction
  • 6. Limulus Amebocyte Lysate: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Lonza Group AG (Switzerland)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Charles River Laboratories, Inc. (United States)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. ASSOCIATES OF CAPE COD, INC. (United States)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Accumedi Solutions Co., Ltd. (China)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Xiamen Bioendo Technology (China)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Zhanjiang A&C Biological (China)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Zhanjiang Bokang (china)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Fuzhou Xinbei (China)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
  • 7. Global Limulus Amebocyte Lysate Sale, by Type, Application, End User and Region (value) (2025-2030)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Research Programs/Design for This Report
  • Table 10. Key Data Information from Secondary Sources
  • Table 11. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 5. Lonza Group AG (Switzerland) Revenue: by Geography 2023
  • Figure 6. Charles River Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 7. Charles River Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 8. ASSOCIATES OF CAPE COD, INC. (United States) Revenue, Net Income and Gross profit
  • Figure 9. ASSOCIATES OF CAPE COD, INC. (United States) Revenue: by Geography 2023
  • Figure 10. Accumedi Solutions Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 11. Accumedi Solutions Co., Ltd. (China) Revenue: by Geography 2023
  • Figure 12. Xiamen Bioendo Technology (China) Revenue, Net Income and Gross profit
  • Figure 13. Xiamen Bioendo Technology (China) Revenue: by Geography 2023
  • Figure 14. Zhanjiang A&C Biological (China) Revenue, Net Income and Gross profit
  • Figure 15. Zhanjiang A&C Biological (China) Revenue: by Geography 2023
  • Figure 16. Zhanjiang Bokang (china) Revenue, Net Income and Gross profit
  • Figure 17. Zhanjiang Bokang (china) Revenue: by Geography 2023
  • Figure 18. Fuzhou Xinbei (China) Revenue, Net Income and Gross profit
  • Figure 19. Fuzhou Xinbei (China) Revenue: by Geography 2023
List of companies from research coverage that are profiled in the study
  • Lonza Group AG (Switzerland)
  • Charles River Laboratories, Inc. (United States)
  • ASSOCIATES OF CAPE COD, INC. (United States)
  • Accumedi Solutions Co., Ltd. (China)
  • Xiamen Bioendo Technology (China)
  • Zhanjiang A&C Biological (China)
  • Zhanjiang Bokang (china)
  • Fuzhou Xinbei (China)
Select User Access Type

Key Highlights of Report


Apr 2024 236 Pages 87 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global and North America Limulus Amebocyte Lysate Market Quantitative research analysis
Global and North America Limulus Amebocyte Lysate Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Lonza Group AG (Switzerland), Charles River Laboratories, Inc. (United States), ASSOCIATES OF CAPE COD, INC. (United States), Accumedi Solutions Co., Ltd. (China), Xiamen Bioendo Technology (China), Zhanjiang A&C Biological (China), Zhanjiang Bokang (china) and Fuzhou Xinbei (China) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"New Laboratory Method like Limulus Amebocyte Lysate (LAL) Test, Used for the Detection of Pyrogenic Endotoxins" is seen as one of major influencing trends for Limulus Amebocyte Lysate Market during projected period 2023-2030.
The Limulus Amebocyte Lysate market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global and North America Limulus Amebocyte Lysate Market Report?

Have a Query? Click Here

Other Related Reports

Fragment-based Drug Discovery Comprehensive Study by Type (Fragment Screening, Fragment Optimization), End-users (Academic and Research Institutions, Biopharmaceutical Companies, Contract Research Or...
$ 3500
Baby Skin Care Comprehensive Study by Type (Natural Product, Pharmaceutical Product, Mass/Generalist Product), Application (Dry Skin, Oily Skin, Flaky Skin), Distribution Channel (Supermarket, Conven...
$ 3650
Buprenorphine Hydrochloride Comprehensive Study by Type (Tablet, Capsule), Application (Analgesic, Opioid Antagonist), Distribution Channel (Online Pharma, Hospital pharma, Retail Pharma) Players and...
$ 3500
Poliomyelitis Vaccine Comprehensive Study by Type (Oral Polio Vaccine (OPV), Inactivated Poliomyelitis Vaccine (IPV)), Application (Hospital, Clinics, Public Services, Others), Route of Administratio...
$ 3450
Measles Vaccine Comprehensive Study by Type (Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)), Application (Pediatric Vaccines, Adult Vaccine...
$ 3450
Meningococcal Vaccines Comprehensive Study by Type (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Others), Application (Pneumonia, Meningitis, Bacteremia, Others (Arthritis, Conj...
$ 3750